PeptiGrowth Series
Growth Factor Alternative Peptide
*Samples are available upon request.
GMP-grade products can be manufactured upon request.
Product Basics
Forging the Path Forward for Cell Therapy and Regenerative Medicine
Growth factors (GF) derived from conventional sources – serum and recombinant proteins – are essential in regenerative medicine.
PeptiGrowth’s proprietary technology offers a range of fully chemically synthesized (animal-component free) peptide growth factors- Growth Factor Alternative Peptide- for use in cell culture media as alternatives to conventional protein growth factors.
Growth Factor Alternative Peptide possess the same capacities for receptor activation, cell proliferation and differentiation as conventional growth factors, but with greater cost effectiveness and ease of use, longer shelf-life, and no contamination by animal-derived components. These peptides provide uniformity in quality that can improve efficiency and data reproducibility and thus reduce the cost of R&D, manufacturing, and quality control.
Key Features
- Cost-efficiency-requires 1/100 to 1/2 the amount compared to recombinant growth factors*
- High scalability can reduce costs further
- Lot-to-lot consistency
- Stable at 37°C, reducing media change frequency
- No toxicity was observed even at 10 uM
- Fully synthetic and animal-free
- ISO 9001:2015 certified
* Varies between products and applications
Technical Information
Comparison with Conventional Products
Compared with conventional growth factors, Growth Factor Alternative Peptide has solved issues such as bio-derived impurities and quality variation problems between production lots.
PeptiGrowth Inc. offers growth factors necessary for stem cell maintenance, proliferation, and differentiation.
Examples of succesful use of PeptiGrowth
- Nerve organoid (Axon) using PG-003 (BDNF alternative peptide)
- Lung alveolar organoid using PG-004 (Noggin-like peptide)
- Natural Killer T cells differentiated from iPSC through HSPC using PG-007 (VEGF). PG-008(Wnt3a) and PG-010 (TPO).
- iPSC-derived skeletal muscle using PG-002(TGFb1 inhibitor alternative peptide)
- Patient-derived intestinal organoids using PG-001(HGF), PG-004(Noggin), PG-008(Wnt3a) and PG-009 (EGF).
- Proliferation of MSC and iPSCs using PG-011(FGF2 alternative peptide)
- Proliferation of human NK cells using PG-013(IL-15 alternative peptide)
Examples of protocols PeptiGrowth can be used as alternatives
FOR RESEARCH USE ONLY, NOT FOR USE IN DIAGNOSTIC PROCEDURES